CRA was retained by the plaintiff in a patent dispute to determine the amount of reasonable royalties due as a result of infringement of a patent by a major medical device company. CRA’s intellectual property expert evaluated the economic and technological comparability of multiple license agreements, the feasibility of non-infringing alternatives, and the Georgia-Pacific factors to determine the appropriate reasonable royalty rate. Dr. Sean Sheridan submitted an expert report and provided testimony in deposition. The case settled prior to trial.
IP Literature Watch: September 2024
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...